Purpose. The aim of this study was to clarify the effect of manipulating intratumor hypoxia on radiosensitivity under reduced dose-rate (RDR) irradiation. Materials and methods. Tumor-bearing mice were continuously given 5-bromo-2′-deoxyuridine (BrdU) to label all proliferating (P) cells. They received γ-rays or accelerated carbon-ion beams at high dose-rate (HDR) or RDR with or without tumor clamping to induce hypoxia. Some mice without clamping received nicotinamide, an acute hypoxia-releasing agent or misonidazole, a hypoxic cell radio-sensitizer before irradiation. The responses of quiescent (Q) and total (= P + Q) cells were assessed by the micronucleus frequency using immunofl uorescence staining for BrdU. Results. The clearer decrease in radiosensitivity in Q than total cells after RDR γ-ray irradiation was suppressed with carbon-ion beams, especially with a higher linear energy transfer value. Repressing the decrease in the radiosensitivity under RDR irradiation through keeping tumors hypoxic during irradiation and enhancing the decrease in the radiosensitivity by nicotinamide were clearer with γ-rays and in total cells than with carbon-ion beams and in Q cells, respectively. Inhibiting the decrease in the radiosensitivity by misonidazole was clearer with γ-rays and in Q cells than with carbon-ion beams and in total cells, respectively. Conclusion. Manipulating hypoxia during RDR as well as HDR irradiation infl uences tumor radiosensitivity, especially with γ-rays.
Introduction
Intensity modulated radiotherapy (IMRT) and stereotactic irradiation have come into common usage as radiotherapy techniques for treating malignancies. Both modalities generally use multiple arc or fi xed-portal radiation beams, and radiation beams are exposed intermittently. These techniques often require 30 min or longer in one treatment session for precise positioning of patients. 1, 2 Prolongation of irradiation time may reduce a radiation effect and evokes a major concern for the dose rate effect. Thus, it is needed to clarify the effect of the reduction of dose rate on the radiosensitivity of tumors in vivo.
When using low linear energy transfer (LET) radiation, lowering the dose rate is thought to reduce late effects in normal tissue much more than it decreases tumor control. Thus, the "therapeutic ratio" increases as the dose rate decreases because the therapeutic ratio is equal to the ratio of tumor control to normal tissue complications. Furthermore, the difference between early and late effects for low dose-rate radiotherapy, as well as improving the therapeutic ratio, allows complete treatment in a short period of time, minimizing the effects of tumor repopulation. In other words, decreasing the dose rate increases the therapeutic ratio, limited only by tumor cell repopulation. 3 This is the primary rationale for low dose-rate radiotherapy using low-LET radiation. High-LET radiation is more effective than low-LET X-or γ-radiation at inducing biological damage. High-LET radiation results in a greater relative biological effectiveness (RBE) value for cell killing, a reduced oxygen effect, and a reduced dependence on the cell cycle and the irradiation dose rate. 4 Manipulating hypoxia in solid tumors during irradiation apparently infl uences tumor radiosensitivity under high-dose-rate (HDR) irradiation using low-LET radiation. 5 However, its signifi cance in solid tumors irradiated at a reduced dose rate (RDR) is less clear in vivo, whether low-or high-LET radiation is employed.
Many cells in solid tumors are quiescent in situ but still clonogenic. 6 The quiescent (Q) tumor cells are more resistant to low-LET radiation because of their larger hypoxic fraction and greater capacity to recover from potentially lethal damage (PLD) than proliferating (P) tumor cells. The rationale for low-dose-rate radiotherapy does not take into account the response of Q tumor cells at all.
Thus, in this study, we tried to elucidate the effect of manipulating hypoxia in irradiated solid tumors at an RDR with low-LET γ-rays or high-LET 290 MeV/u accelerated carbon-ion beams in vivo, compared with HDR irradiation. Furthermore, the responses of the total (= P + Q) and Q cell populations in irradiated solid tumors were separately detected with the method for selectively detecting the response of Q cells in solid tumors. 7 This is the fi rst attempt to clarify the direct relation between the irradiation dose rate effect and the oxygen effect in vivo, referring to the response of the Q cell population in irradiated solid tumors.
Materials and methods

Mice and tumors
Squamous cell carcinoma cell line VII (SCC VII) derived from C3H/He mice was maintained in vitro in Eagle's minimum essential medium supplemented with 12.5% fetal bovine serum. The tumor cells (1.0 × 10 5 ) were inoculated subcutaneously into the left hind leg of 9-week-old syngeneic female C3H/He mice (Japan Animal Co., Osaka, Japan). Fourteen days later, the tumors, approximately 1 cm in diameter, were employed for experimental treatment, and the body weight of the tumor-bearing mice was 22.1 ± 2.3 g (mean ± SD). Mice were handled according to the Recommendations for Handling of Laboratory Animals for Biomedical Research, compiled by the Committee on Safety Handling Regulations for Laboratory Animal Experiments. Incidentally, the p53 of SCC VII tumor cells is the wild type. 7 Labeling with 5-bromo-2′-deoxyuridine Nine days after the inoculation, miniosmotic pumps (Durect, Cupertino, CA, USA) containing 5-bromo-2′-deoxyuridine (BrdU) dissolved in physiological saline (250 mg/ml) were implanted subcutaneously to label all P cells for 5 days. The percentage of labeled cells after continuous labeling with BrdU was 55.3% ± 4.5% and reached a plateau at this stage. Therefore, tumor cells not incorporating BrdU after continuous labeling were regarded as Q cells.
Treatment
After the labeling with BrdU, tumor-bearing mice underwent γ-ray or accelerated carbon-ion whole-body irradiation, with the animal held in a specially designed device made of acrylic resin with the tail or all four legs fi rmly fi xed with adhesive tape with no anesthetic. Some tumors were made totally hypoxic by clamping the proximal end 15 min before irradiation. 7 This clamping for 15 min did not infl uence clonogenic cell survival or the level of micronucleation. γ-Rays were delivered with a cobalt-60 γ-ray irradiator at a dose rate of 2.5 or 0.039 Gy/min.
Carbon-12 ions were accelerated up to 290 MeV/u by the synchrotron of the Heavy Ion Medical Accelerator installed at National Institute of Radiological Sciences in Chiba, Japan. The dose rate was regulated through a beam attenuation system, and irradiation was conducted using horizontal carbon beams with a dose rate of 1.0 or 0.035 Gy/min. The LET of the carbon ion beam with the 6-cm spread-out Bragg peak (SOBP) ranges from 14 keV/ μm to >200 keV/μm, depending on depth. A desired LET beam was obtained by selecting the depth along the beam path using a Lucite range shifter. LETs of 18 and 50 keV/μm at the middle of the plateau and the SOBP, respectively, were employed here. 8 Irradiated tumor-bearing mice were divided into four groups: group I, tumors were excised immediately after irradiation only under aerated conditions; group II, tumors were kept totally hypoxic during irradiation, then excised immediately after irradiation; group III, tumor-bearing mice received intraperitoneal administration of an acute hypoxia-releasing agent, nicotinamide (1000 mg/kg mouse weight) dissolved in physiological saline 60 min before irradiation, after which the tumors were excised immediately under aerated conditions; group IV, tumor-bearing mice received intraperitoneal administration of a hypoxic cell radiosensitizer, misonidazole (1000 mg/kg of mouse weight) dissolved in physiological saline 30 min before irradiation, after which the tumors were excised immediately under aerated conditions. All the doses employed, sequences, and timing for nicotinamide, misonidazole, and irradiation were appropriate enough to function completely. 9, 10 Each treatment group also included mice not pretreated with BrdU.
Immunofl uorescence staining of BrdU-labeled cells and micronucleus assay Tumors excised from the mice given BrdU were minced and trypsinized [0.05% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA) in phosphate-buffered saline (PBS), 37°C, 20 min]. Tumor cell suspensions were incubated for 72 h in tissue culture dishes containing complete medium and cytochalasin-B of 1.0 μg/ml to inhibit cytokinesis while allowing nuclear division. The cultures were then trypsinized, and cell suspensions were fi xed. After centrifugation of fi xed cell suspensions, the cell pellet was resuspended with cold Carnoy's fi xative (ethanol/acetic acid ratio was 3 : 1 vol/vol). The suspension was placed on a glass microscope slide, and the sample was dried at room temperature. The slides were treated with 2 M hydrochloric acid for 60 min at room temperature to dissociate the histones and partially denature the DNA. The slides were immersed in boraxborate buffer (pH 8.5) to neutralize the acid. BrdUlabeled tumor cells were detected by indirect immunofl uorescence staining using a monoclonal antiBrdU antibody (Becton Dickinson, San Jose, CA, USA) and a fl uorescein isothiocyanate (FITC)-conjugated anti-mouse immunoglobulin G (IgG) antibody (Sigma, St. Louis, MO, USA). To observe the double staining of tumor cells with green-emitting FITC and red-emitting propidium iodide (PI), cells on the slides were treated with PI in PBS (2 μg/ml) and monitored under a fl uorescence microscope.
The micronucleus (MN) frequency in cells not labeled with BrdU could be examined by counting the micronuclei in the binuclear cells that showed only red fl uorescence. The MN frequency was defi ned as the ratio of the number of micronuclei in the binuclear cells to the total number of binuclear cells observed. 7 The MN frequency has already been shown to be a tool for detecting radiosensitivity to carbon-ion beams.
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The ratios obtained in tumors not pretreated with BrdU indicated the MN frequency at all phases in the total tumor cell population. More than 400 binuclear cells were counted to determine the MN frequency.
Clonogenic cell survival assay
The clonogenic cell survival assay was also performed in the mice given no BrdU using an in vivo-in vitro assay method. Tumors were disaggregated by stirring for 20 min at 37°C in PBS containing 0.05% trypsin and 0.02% EDTA. The cell yield was 4.5 ± 1.1 × 10 7 /g tumor weight.
As stated above, the MN frequencies for Q cells were obtained from nonlabeled tumor cells after continuous BrdU labeling. The MN frequencies and surviving fractions (SFs) for the total cell population were obtained from cells in tumors not pretreated with BrdU. Thus, there was no effect of interaction between BrdU and irradiation on the values of MN frequency and SFs. More than three tumor-bearing mice were used to assess each set of conditions, and each experiment was repeated at least twice.
To examine the differences between pairs of values, Student's t-test was used when variances of the two groups could be assumed to be equal. Otherwise, the Welch t-test was used.
Results
The plating effi ciency and MN frequency at 0 Gy are shown in Table 1 . The plating effi ciency was signifi cantly smaller for the combination with MISO than for any other condition in the total cell population. In both the total and Q cell populations, the MN frequency significantly increased in the following order: absolute control < totally hypoxic conditions < combination with nicotinamide < combination with misonidazole. Furthermore, the MN frequency was signifi cantly higher for the Q cell population than for the total cell population under all conditions. Cell survival curves for the total tumor cells as a function of radiation dose after γ-ray irradiation are shown in Fig. 1 . For both HDR and RDR irradiation, the SFs decreased in the following order: irradiation under totally hypoxic conditions > aerobic irradiation without any drug > irradiation after nicotinamide loading > irradiation after misonidazole loading. The SFs under all conditions increased as the dose rate of radiation decreased, especially after nicotinamide loading.
Cell survival curves for the total tumor cells as a function of radiation dose after accelerated carbon-ion beam irradiation with an LET of 18 and 50 keV/μm are shown in the left and right panels of Fig. 2 , respectively. For both HDR and RDR irradiation, the SFs decreased in the same order as for γ-ray irradiation, but the degree of change was reduced, especially with 50 keV/μm carbonion beams. The increases in the SF with the decrease in dose rate were suppressed compared with γ-ray irradiation, again especially with 50 keV/μm carbon-ion beams.
For baseline correction, we used the normalized MN frequency to exclude the MN frequency in nonirradiated tumors. The normalized MN frequency was the MN frequency in the irradiated tumors minus that in the nonirradiated tumors. Dose-response curves of the normalized MN frequency for total and Q tumor cell populations as a function of radiation dose after γ-ray irradiation are shown in the left and right panels of Fig.  3 , respectively. Overall, the normalized MN frequencies were signifi cantly smaller in Q cells than in the total cells. In both total and Q cells, under RDR as well as HDR irradiation, the normalized MN frequencies increased in the following order: irradiation under totally hypoxic conditions < aerobic irradiation without drugs < irradiation after nicotinamide loading < irradiation after misonidazole loading. The normalized MN frequencies decreased with the decrease in dose rate under all conditions, especially irradiation after nicotinamide loading in the total cell population.
Dose-response curves of the normalized MN frequency for the total and Q tumor cells as a function of radiation dose after accelerated carbon-ion beam irradiation with an LET of 18 (Fig. 4) or 50 keV/μm (Fig. 5) are shown in the left and right panels, respectively. Overall, the normalized MN frequencies were signifi cantly smaller in Q cells than total cells, but the differences in radiosensitivity between the total and Q cells were reduced compared with γ-ray irradiation, especially with 50 keV/μm carbon-ion beams. In both the total and Q cells, under RDR as well as HDR irradiation, the normalized MN frequencies increased in the same order as for γ-ray irradiation, but the degree of change was reduced, especially with 50 keV/ μm carbon-ion beams. The decreases in the normalized MN frequency with the decrease in radiation dose rate were suppressed compared with γ-ray irradiation, again especially with 50 keV/μm carbon-ion beams.
To estimate the effect of aerobic irradiation compared with hypoxic irradiation in both the total and Q cells, the data for aerobic irradiation without any drug and irradiation under totally hypoxic conditions were used Results are the mean ± standard deviation Values in parentheses are 95% confi dence limits, determined using standard errors. If the ranges of 95% confi dence limits showed no overlap between any two values, the difference between the two values was considered signifi cant (P < 0.05) a The ratio of the dose of radiation necessary to obtain each endpoint under hypoxic conditions to that needed to obtain each endpoint under aerobic conditions (Table 2) . Following γ-ray irradiation, the values were signifi cantly smaller for Q cells than for the total cells (P < 0.05), and in both the total and Q cells the values were signifi cantly smaller for RDR than HDR irradiation (P < 0.05). In both populations, carbon-ion beams produced signifi cantly smaller values than γ-rays (P < 0.05), and the values approached 1.0 as the LET values increased.
To assess the radio-enhancing effect of nicotinamide or misonidazole under aerobic conditions in both the total and Q cells compared with aerobic irradiation without any drug, the data for aerobic irradiation with and without drugs were used ( Table 3 ). The enhancing effect of nicotinamide was more marked in the total cell population, especially with HDR γ-ray irradiation. The effect was little observed for RDR γ-ray irradiation and accelerated carbon-ion irradiation especially with a higher LET value. In contrast, the enhancing effect of misonidazole was more marked in the Q cells. The enhancing effect was also attenuated for accelerated carbon-ion irradiation, especially with a higher LET value.
To investigate the reduction in radiosensitivity caused by a decrease in the radiation dose rate, dose-modifying factors were calculated using the data for all irradiation conditions given in Figs. 1-5 (Table 4) . On the whole, the reduction in radiosensitivity was more marked in Q cells than in the total cells, especially under γ-ray irradiation. In the total cells, the degree of the reduction of radiosensitivity was reduced in the following order: aerobic irradiation with nicotinamide > aerobic irradiation without any drug > aerobic irradiation with misonidazole > irradiation under totally hypoxic conditions. In Q cells, the degree of the reduction of radiosensitivity was reduced in the following order: aerobic irradiation with nicotinamide = aerobic irradiation without any drug > irradiation under totally hypoxic conditions > aerobic irradiation with misonidazole. This order of the reduction in radiosensitivity and the difference in the reduction in radiosensitivity between Q cells and the total cells became more indistinct with the use of accelerated carbon-ion beams, especially at a higher LET value, than with the use of γ-rays.
To examine the difference in radiosensitivity between the total and Q cells, dose-modifying factors⎯which allow us to compare the dose of radiation necessary to obtain a normalized MN frequency of 0.2 in Q cells with that in the total cells⎯were calculated using the data in Figs. 3-5 (Table 5) . Overall, the difference in radiosensitivity was greater under RDR than HDR irradiation, especially with γ-rays. The difference in radiosensitivity increased in the following order: irradiation under totally hypoxic conditions < aerobic irradiation with misonidazole < aerobic irradiation without any drug ≤ aerobic irradiation with nicotinamide. This order of the increase in the difference in radiosensitivity and the difference itself in radiosensitivity became more indistinct with the use of accelerated carbon-ion beams, especially at a higher LET value, than with the use of γ-rays. Values in parentheses are 95% confi dence limits, determined using standard errors. If the ranges of 95% confi dence limits showed no overlap between any two values, the difference between the two values was considered signifi cant (P < 0.05) a The ratio of the dose of radiation necessary to obtain each end-point without the drug to that needed to obtain each end-point with the drug. Values in parentheses are 95% confi dence limits, determined using standard errors. If the ranges of 95% confi dence limits showed no overlap between any two values, the difference between the two values was considered signifi cant (P < 0.05) a The ratio of the dose of radiation necessary to obtain each end-point with reduced dose-rate irradiation to that needed to obtain each end-point with high dose-rate irradiation. Values in parentheses are 95% confi dence limits, determined using standard errors. If the ranges of 95% confi dence limits showed no overlap between any two values, the difference between the two values was considered signifi cant (P < 0.05) a The ratio of the dose of radiation necessary to obtain each normalized micronucleus frequency in quiescent cell population to that needed to obtain each normalized micronucleus frequency in total tumor cell population
Discussion
Solid tumors, especially human tumors, are thought to contain a high proportion of Q cells. 6 The presence of Q cells is probably due, in part, to hypoxia and depletion of nutrients in the tumor core, another consequence of poor vascular supply. 6 This might promote the formation of micronuclei at 0 Gy in Q tumor cells (Table 1) . Q cells were shown to have signifi cantly less radiosensitivity than the total cells here (Figs. 3-5 ). This means that more Q cells survive radiation therapy than P cells. Thus, control of Q cells has a great impact on the outcome of radiation therapy. In both the total and Q cell populations, carbon ion irradiation was less dependent on oxygenation status with little recovery from radiation-induced DNA damage, leading to high RBE values compared with γ-ray irradiation. 11 In terms of the tumor cell-killing effect as a whole, including intratumor Q cell control, carbon-ion beam radiotherapy can be a promising treatment for refractory tumors.
The Q cell population had been shown to include a signifi cantly larger hypoxic fraction than the total cell population, 12 resulting in a signifi cantly smaller effect of carbon-ion beams under aerobic irradiation compared with hypoxic irradiation in Q cells ( Table 2 ). As tumor radiosensitivity was signifi cantly less dependent on intratumor oxygenation status and the irradiation dose rate effect when carbon-ion beams, especially with a higher LET value, were used, a much smaller effect of aerobic irradiation compared with hypoxic irradiation was observed here. This was partly because the frequency of closely spaced DNA lesions forming a cluster of DNA damage produced by high-LET carbon-ion irradiation is much less dependent on oxygenation status at the time of irradiation than that of DNA damage produced by low-LET γ-ray irradiation. 13 Tumor hypoxia is a direct consequence of structural abnormalities of the microvasculature and functional abnormalities of the microcirculation in solid tumors and results from either limited oxygen diffusion (chronic hypoxia) or limited perfusion (acute hypoxia, transient hypoxia, or ischemic hypoxia). Large intercapillary distances resulting from rapid tumor cell proliferation lead to chronically hypoxic cells existing at the rim of the oxygen diffusion distance.
14 Factors such as vessel plugging by blood cells or circulating tumor cells, the collapse of vessels in regions of high tumor interstitial pressure, and spontaneous vasomotor activity in normal tissue vessels incorporated into the tumor⎯which subsequently affects fl ow in downstream tumor microvessels⎯cause intermittent blood fl ow in tumors, which results in acute hypoxia. 15 Thus, acute hypoxic areas are distributed throughout the tumor depending on these causative factors and can occur sporadically in large areas of a solid tumor.
Nicotinamide, a vitamin B 3 analog, is known to prevent these transient fl uctuations in tumor blood fl ow that lead to the development of acute hypoxia. 9 Misonidazole is a typical 2-nitro-imidazole hypoxic cell sensitizer that is thought to function as an oxygen-mimicking agent in intratumor hypoxic areas under irradiation. 10 In SCC VII tumors, it has been shown that the hypoxic fraction of the total cell population is predominantly made up of acute hypoxic areas and that of the hypoxiarich Q cell population is mainly made up of chronic hypoxic areas. 12 Therefore, under HDR γ-ray irradiation, the enhancement ratio of nicotinamide was higher in the total cells than in Q cells, and that of misonidazole was higher in the Q cells (Table 3) . When carbon-ion beams, especially with a higher LET value, were employed, these differences in the enhancement ratio were reduced because radiosensitivity was much less dependent on intratumor oxygenation status. 11 However, under RDR γ-ray irradiation, acute hypoxic areas appear and disappear throughout a solid tumor during long periods of irradiation. 15 As a result, RDR irradiation even without nicotinamide could make it possible to irradiate all acute hypoxic areas under oxic conditions, leading to no radio-enhancing effect of nicotinamide. The radio-enhancing effect of misonidazole, which depends on the size of the hypoxic fraction in solid tumors, however, still could be observed under RDR as well as HDR irradiation.
Enhancement of the irradiation dose rate effect on the normalized frequency of micronuclei by γ-ray irradiation in the presence of nicotinamide compared with γ-ray irradiation alone was observed in the acute hypoxia-rich total cells rather than the chronic hypoxia-rich Q cells ( Table 4) . Suppression of the dose rate effect by inducing total hypoxia during irradiation was slightly more clearly observed in normoxia-rich total cells than hypoxia-rich Q cells. Some recent in vitro studies found that hypoxiainduced translational repression can explain the decreased homologous recombination (HR) repair of radiationinduced DNA double-stranded breaks (dsbs), 16 a more important mechanism for the repair of dsbs in late-S and G 2 growth phases, and that HR plays a greater role in determining hypoxic radiosensitivity than normoxic radiosensitivity. 17 Thus, the use of nicotinamide or tumor clamping to induce total hypoxia infl uenced repair more in the total cells including late-S and G 2 phase cells than in Q cells. In contrast, the repression of the dose rate effect by the hypoxic cell radiosensitizer misonidazole was slightly more clearly observed in the hypoxia-rich Q cells than in normoxia-rich total cells. It had already been shown that the loading of misonidazole after low-LET HDR irradiation to solid tumors inhibited the recovery from radiation-induced PLD in vivo, especially in Q cells. 18 This study showed that misonidazole combined with low-LET RDR irradiation could suppress the dose rate effect, especially in Q cells. According to the previous fi nding that the recovery from PLD and the decrease in radiosensitivity through a reduction in the irradiation dose rate under low-LET irradiation are mainly due to non-homologous end-joining (NHEJ) repair, which is the predominant DNA dsbs repair process for cells in G 0 , G 1 , or early-S phase, 19 misonidazole itself or protein adducts of reductively-activated misonidazole in hypoxic areas in irradiated tumors may inhibit NHEJ more effi ciently than HR. 10 Again, when carbon-ion beams, especially with a higher LET value, were employed, the effects of combined treatment on the irradiation dose rate effect became indistinct because radiosensitivity was much less dependent on intratumor oxygenation status and the irradiation dose rate. 11 Overall, the difference in radiosensitivity between the total and Q cells was increased by reducing the dose rate, especially for γ-ray irradiation, because of the greater reduction in radiosensitivity caused by a decrease in the dose rate in Q cells than in the total cells 9 (Table 5) . Nicotinamide enhanced the radiosensitivity of the total cells, leading to widening of the difference in radiosensitivity between the total and Q cell populations compared with aerobic HDR γ-ray irradiation without any drug. However, for RDR γ-ray irradiation, the effect of nicotinamide disappeared owing to the characteristics of acute hypoxia in solid tumors, resulting in no change in the difference in radiosensitivity between the total and Q cells compared with γ-ray irradiation alone. Meanwhile, under totally hypoxic conditions, the difference in radiosensitivity was smaller than for aerobic γ-ray irradiation because of the radioresistance induced by total hypoxia in both the total and Q cell populations in sold tumors. Misonidazole enhanced the radiosensitivity of the hypoxia-rich Q cells much more than that of the total cells under both HDR and RDR γ-ray irradiation, leading to a decrease in the difference in radiosensitivity between the two cells compared with aerobic γ-ray irradiation alone. When carbon-ion beams, especially with a higher LET value, were employed, the effects of combined treatment on the difference in radiosensitivity between the total and Q cells became indistinct because tumor radiosensitivity was much less dependent on intratumor oxygenation status and the irradiation dose rate. 11 Anyway, at least in this study, it was elucidated that manipulating hypoxia during RDR irradiation, especially with γ-rays, infl uences tumor radiosensitivity as well as HDR irradiation in both total and Q cell populations. In radiotherapy, the irradiation dose rate also should be taken into account when intratumor hypoxia is manipulated.
